tiprankstipranks
N4 Pharma PLC (GB:N4P)
LSE:N4P
UK Market

N4 Pharma (N4P) Income Statement

Compare
3 Followers

N4 Pharma Income Statement

Last quarter (Q2 2024), N4 Pharma's total revenue was £3.91K, an increase of Infinity% from the same quarter last year. In Q2, N4 Pharma's net income was £-454.87K. See N4 Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 1.95K£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ 1.95K£ 0.00£ 0.00£ 0.00£ 0.00
Operating Expenses
£ 1.43M£ 1.19M£ 1.84M£ 1.56M£ 947.34K
Depreciation and Amortization
£ 89.17K£ 228.49K£ 236.56K£ 206.30K£ 171.86K
EBITDA
£ -1.34M£ -1.19M£ -1.84M£ -1.56M£ -947.34K
Operating Income
£ -1.42M£ -1.19M£ -1.84M£ -1.56M£ -947.34K
Other Income/Expenses
£ 0.00£ 1.00£ 677.00£ -1.96K£ -1.39K
Pretax Income
£ -1.42M£ -1.19M£ -1.84M£ -1.57M£ -948.73K
Net Income
£ -1.27M£ -1.03M£ -1.54M£ -1.30M£ -876.37K
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -0.01£ -0.01£ -0.01£ -0.01£ -0.01
Diluted EPS
£ -0.01£ -0.01£ -0.01£ -0.01£ -0.01
Weighted Average Shares Outstanding
242.89M 186.42M 181.08M 136.30M 100.17M
Weighted Average Shares Outstanding (Diluted)
242.89M 186.42M 181.08M 136.30M 100.17M
Currency in GBP

N4 Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis